Optovue Announces Expanded FDA Clearance of Epithelial Thickness Mapping

FREMONT, Calif.--(BUSINESS WIRE)--Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), today announced an expanded FDA 510(k) clearance for non-contact, quantitative measurements of the epithelial and stromal layers of the cornea, termed epithelial thickness mapping or ETM. The expanded clearance adds a nine-millimeter ETM scan to the previously available six-millimeter map, allowing for detection of epithelial irregularities in an area

Full Story →